SOW
CNTA

State of Wyoming’s Centessa Pharmaceuticals CNTA Stock Holding History

State of Wyoming’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-96
Closed – – 1593
2022
Q2 		$0 Buy
96
+23
+32% +$147 ﹤0.01% 1915
2022
Q1 		$1K Buy
73
+12
+20% +$109 ﹤0.01% 1731
2021
Q4 		$1K Buy
61
+38
+165% +$511 ﹤0.01% 1800
2021
Q3 		$0 Buy
+23
New +$476 ﹤0.01% 1232

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State of Wyoming's CNTA Position: Q3 2022 in Review

State of Wyoming sold out of Centessa Pharmaceuticals (CNTA) in Q3 2022, closing a stake of 96 shares.

State of Wyoming first reported a position in CNTA in Q3 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 44 funds tracked by Wall St. Rank hold CNTA as of Q3 2022.

  • State of Wyoming reported no remaining Centessa Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 96 Centessa Pharmaceuticals shares in Q3 2022.
  • State of Wyoming first reported a position in Centessa Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • State of Wyoming's Centessa Pharmaceuticals position peaked at $1K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.